Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemung Financial (CHMG) Cash & Equivalents (2016 - 2025)

Chemung Financial (CHMG) has disclosed Cash & Equivalents for 10 consecutive years, with $50.1 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 6.51% to $50.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $50.1 million through Dec 2025, up 6.51% year-over-year, with the annual reading at $50.1 million for FY2025, 6.51% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $50.1 million at Chemung Financial, down from $107.6 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $320.1 million in Q2 2025, with the low at $2.5 million in Q4 2021.
  • Average Cash & Equivalents over 5 years is $70.7 million, with a median of $55.5 million recorded in 2021.
  • The sharpest move saw Cash & Equivalents tumbled 63.4% in 2021, then surged 608.89% in 2024.
  • Over 5 years, Cash & Equivalents stood at $2.5 million in 2021, then rose by 9.5% to $2.7 million in 2022, then skyrocketed by 145.01% to $6.6 million in 2023, then soared by 608.89% to $47.0 million in 2024, then increased by 6.51% to $50.1 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $50.1 million, $107.6 million, and $320.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.